Thus, our findings reveal that DNMT3B -283T/C is associated with cancer risk, whereas DHFR 19-pb ins/del and TYMS 28-bp tandem repeat polymorphisms have a protective effect against head and neck cancer in relation to that in the control group. Here, DHFR is linked to cancer.